Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.

Mirili, Cem; Yilmaz, Ali; Demirkan, Serkan; Bilici, Mehmet; Basol Tekin, Salim

Mirili, Cem; Yilmaz, Ali; Demirkan, Serkan; Bilici, Mehmet; Basol Tekin, Salim.

Affiliation

Mirili C; Department of Medical Oncology, Ataturk University Faculty of Medicine, 25050, Yakutiye, Erzurum, Turkey. cemirili@gmail.com.
Yilmaz A; Department of Medical Oncology, Ataturk University Faculty of Medicine, 25050, Yakutiye, Erzurum, Turkey.
Demirkan S; Department of Dermatology, Katip Çelebi University Ataturk Education and Research Hospital, Izmir, Turkey.
Bilici M; Department of Medical Oncology, Ataturk University Faculty of Medicine, 25050, Yakutiye, Erzurum, Turkey.
Basol Tekin S; Department of Medical Oncology, Ataturk University Faculty of Medicine, 25050, Yakutiye, Erzurum, Turkey.

Int J Clin Oncol ; 24(10): 1301-1310, 2019 Oct.

Article de En | MEDLINE | ID: mdl-31073814

Sujet(s)
Mots clés

Malignant melanoma; Neutrophillymphocyte ratio; Prognostic nutritional index; Systemic immune-inflammation index

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes / Marqueurs biologiques / Évaluation de l'état nutritionnel / État nutritionnel / Inflammation / Mélanome / Granulocytes neutrophiles Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Int J Clin Oncol Sujet du journal: NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google